TMFEBCapital

Todd Campbell

TMFEBCapital’s Activity

Yesterday

NL

Article

EBCapitalMarkets published an article 3:54 PM

Johnson & Johnson Just Stepped Up Its Hepatitis C Game

Johnson & Johnson has inked a licensing deal with Achillion Pharmaceuticals that could threaten Gilead Sciences market share in hepatitis C. Should Gilead investors worry?

NL

Article

EBCapitalMarkets published an article 1:30 PM

Why Shares in Bluebird bio, Inc. Are Soaring

Bluebird bio is surging higher on optimism for Lentiglobin BB305.

NL

Article

EBCapitalMarkets published an article 8:59 AM

MannKind, Front and Center: The Best Product Doesn’t Always Equal the Best Stock

The Motley Fool's own Michael Douglass and Todd Campbell dig into MannKind Corp.'s first quarter earnings to see if MannKind is a bargain, or a bust.

Wed May 20

NL

Article

EBCapitalMarkets published an article 11:33 AM

Why Achillion Pharmaceuticals, Inc. Shares Are Collapsing

Achillion Pharmaceuticals, Inc. investors are disappointed that Johnson & Johnson isn't buying the company outright.

NL

Article

EBCapitalMarkets published an article 11:14 AM

Johnson & Johnson Takes On Gilead Sciences in Hep C... Again

Johnson & Johnson's deal with Achillion Pharmaceuticals positions it to challenge Gilead Sciences' dominance in hepatitis C treatment.

Tue May 19

NL

Article

EBCapitalMarkets published an article 4:43 PM

Billionaires Are Flocking to These Stocks -- Should You, Too?

Warren Buffett, George Soros, and David Einhorn picked up shares in these three big-cap companies last quarter.

NL

Article

EBCapitalMarkets published an article 11:41 AM

Why Intercept Pharmaceuticals Shares Are Tumbling

Intercept Pharmaceuticals has nailed down the details for its upcoming late stage study for the treatment of NASH.

Mon May 18

NL

Article

EBCapitalMarkets published an article 3:49 PM

Why Achillion Pharmaceuticals, Inc. Shares Soared Today

Achillion Pharmaceuticals shares are heading higher on hopes that a suitor may emerge.

Fri May 15

NL

Article

EBCapitalMarkets published an article 4:39 PM

The Best Blue Chips to Own Forever

One Motley Fool offers up his top blue-chip stocks to own in long-term portfolios.

NL

Article

EBCapitalMarkets published an article 3:02 PM

This Approval Sends Pernix Therapeutics Holdings Inc. Shares Soaring

Pernix Therapeutics Holdings has secured pediatric approval for its migraine drug Treximet.

NL

Article

EBCapitalMarkets published an article 1:17 PM

Here's Why Sorrento Therapeutics, Inc Shares Are Soaring

Sorrento Therapeutics shares are climbing thanks to a deal with Abraxane's inventor.

NL

Article

EBCapitalMarkets published an article 10:43 AM

Disposable Income: How You Can Boost It

A Motley Fool explains disposable income and offers a few tips on how to increase it.

Thu May 14

NL

Article

EBCapitalMarkets published an article 3:35 PM

Americans' Average Net Worth by Age -- How Do You Compare?

American's net worth may not be enough to offer financial security in retirement.

NL

Article

EBCapitalMarkets published an article 12:46 PM

Why This Data Is Making Puma Biotechnology, Inc Shares Collapse

Puma Biotechnology, Inc. shares collapsed after abstract data for neratinib disappointed investors.

NL

Article

EBCapitalMarkets published an article 11:56 AM

What Is an Abbreviated New Drug Application, And What Does It Mean to Investors?

A Motley Fool analyst sheds light on abbreviated drug applications and their potential impact on investors.

Tue May 12

NL

Article

EBCapitalMarkets published an article 5:54 PM

Who Is the Richest Woman in the World?

Christy Walton clocks in as the planet's wealthiest woman, with a net worth of more than $40 billion.

NL

Article

EBCapitalMarkets published an article 12:34 PM

Why NewLink Genetics Corporation Shares Crashed

Shares in NewLink Genetics Corporation are tumbling on news that a key trial will continue, rather than end early.

Mon May 11

NL

Article

EBCapitalMarkets published an article 1:31 PM

Idera Pharmaceuticals, Inc. Shares Soar On Earnings

Shares are trading higher on optimism following Idera Pharmaceuticals' first quarter financial results.

NL

Article

EBCapitalMarkets published an article 10:22 AM

This Marijuana Stock's Expenses Are Soaring

GW Pharmaceuticals is spending heavily to research medical marijuana.

Sun May 10

NL

Article

EBCapitalMarkets published an article 1:03 PM

Investors Just Doubled Their Money on This Stock

Alexion is paying $8.4 billion to buy Synageva, a company without any sales, so in today's episode we're digging into this deal to see what it may mean to biotech investors.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 53.35
Player Rank 35096 out of 75223
Score 54.09
Score Change Today -17.06
Accuracy 50.00%
Active Picks 34
Total Picks 34
Best Pick MDVN (+94.61)
Worst Pick KBH (-56.33)
Average Score per Pick 1.59
Charms Earned 6
Highest Rated Favorite No Favorites Selected
Go to TMFEBCapital’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFEBCapital’s 10 Latest Posts